UP-regulation of ANLN is observed in various human malignancies and exhibits a poor prognosis of cancers, such as in nasopharyngeal carcinoma (NPC) [43], lung cancer [44], colorectal cancer (CRC) [47], cervical cancer [48] and breast cancer [45, 49]. This evidence concerns the gene ANLN and breast carcinoma.